431 related articles for article (PubMed ID: 28556553)
1. Tailoring Biomaterials for Cancer Immunotherapy: Emerging Trends and Future Outlook.
Wang C; Ye Y; Hu Q; Bellotti A; Gu Z
Adv Mater; 2017 Aug; 29(29):. PubMed ID: 28556553
[TBL] [Abstract][Full Text] [Related]
2. Nanomedicine to modulate immunotherapy in cutaneous melanoma (Review).
Volovat SR; Negru S; Stolniceanu CR; Volovat C; Lungulescu C; Scripcariu D; Cobzeanu BM; Stefanescu C; Grigorescu C; Augustin I; Lupascu Ursulescu C; Volovat CC
Exp Ther Med; 2021 May; 21(5):535. PubMed ID: 33815608
[TBL] [Abstract][Full Text] [Related]
3. Surgery-free injectable macroscale biomaterials for local cancer immunotherapy.
Lei K; Tang L
Biomater Sci; 2019 Feb; 7(3):733-749. PubMed ID: 30637428
[TBL] [Abstract][Full Text] [Related]
4. Biomaterials as Local Niches for Immunomodulation.
Adu-Berchie K; Mooney DJ
Acc Chem Res; 2020 Sep; 53(9):1749-1760. PubMed ID: 32786230
[TBL] [Abstract][Full Text] [Related]
5. Local biomaterials-assisted cancer immunotherapy to trigger systemic antitumor responses.
Chen Q; Chen M; Liu Z
Chem Soc Rev; 2019 Nov; 48(22):5506-5526. PubMed ID: 31589233
[TBL] [Abstract][Full Text] [Related]
6. Delivery strategies of cancer immunotherapy: recent advances and future perspectives.
Zhao Z; Zheng L; Chen W; Weng W; Song J; Ji J
J Hematol Oncol; 2019 Nov; 12(1):126. PubMed ID: 31779642
[TBL] [Abstract][Full Text] [Related]
7. Advances in immunotherapy delivery from implantable and injectable biomaterials.
Leach DG; Young S; Hartgerink JD
Acta Biomater; 2019 Apr; 88():15-31. PubMed ID: 30771535
[TBL] [Abstract][Full Text] [Related]
8. Immunoengineering with biomaterials for enhanced cancer immunotherapy.
Xie YQ; Wei L; Tang L
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2018 Jul; 10(4):e1506. PubMed ID: 29333729
[TBL] [Abstract][Full Text] [Related]
9. Prospects for personalized combination immunotherapy for solid tumors based on adoptive cell therapies and immune checkpoint blockade therapies.
Kato D; Yaguchi T; Iwata T; Morii K; Nakagawa T; Nishimura R; Kawakami Y
Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(1):68-77. PubMed ID: 28539557
[TBL] [Abstract][Full Text] [Related]
10. Cellular Bioparticulates with Therapeutics for Cancer Immunotherapy.
Wang C; Wen D; Gu Z
Bioconjug Chem; 2018 Mar; 29(3):702-708. PubMed ID: 29227626
[TBL] [Abstract][Full Text] [Related]
11. Nanomaterials as Smart Immunomodulator Delivery System for Enhanced Cancer Therapy.
Yuan C; Liu Y; Wang T; Sun M; Chen X
ACS Biomater Sci Eng; 2020 Sep; 6(9):4774-4798. PubMed ID: 33455212
[TBL] [Abstract][Full Text] [Related]
12. Advanced biomaterials for cancer immunotherapy.
Yang F; Shi K; Jia YP; Hao Y; Peng JR; Qian ZY
Acta Pharmacol Sin; 2020 Jul; 41(7):911-927. PubMed ID: 32123302
[TBL] [Abstract][Full Text] [Related]
13. Boosting Checkpoint Immunotherapy with Biomaterials.
Liu L; Pan Y; Zhao C; Huang P; Chen X; Rao L
ACS Nano; 2023 Feb; 17(4):3225-3258. PubMed ID: 36746639
[TBL] [Abstract][Full Text] [Related]
14. Advanced Biomaterials with Intrinsic Immunomodulation Effects for Cancer Immunotherapy.
Chen W; Li C; Jiang X
Small Methods; 2023 May; 7(5):e2201404. PubMed ID: 36811240
[TBL] [Abstract][Full Text] [Related]
15. Boolean logic in synthetic biology and biomaterials: Towards living materials in mammalian cell therapeutics.
Bressler EM; Adams S; Liu R; Colson YL; Wong WW; Grinstaff MW
Clin Transl Med; 2023 Jul; 13(7):e1244. PubMed ID: 37386762
[TBL] [Abstract][Full Text] [Related]
16. Biomaterial-assisted photoimmunotherapy for cancer.
Chen M; Chen Q
Biomater Sci; 2020 Nov; 8(21):5846-5858. PubMed ID: 33016276
[TBL] [Abstract][Full Text] [Related]
17. Recent Advances in Polymeric Nanomedicines for Cancer Immunotherapy.
Lee ES; Shin JM; Son S; Ko H; Um W; Song SH; Lee JA; Park JH
Adv Healthc Mater; 2019 Feb; 8(4):e1801320. PubMed ID: 30666822
[TBL] [Abstract][Full Text] [Related]
18. Improving Cancer Immunotherapy Outcomes Using Biomaterials.
Yan S; Luo Z; Li Z; Wang Y; Tao J; Gong C; Liu X
Angew Chem Int Ed Engl; 2020 Sep; 59(40):17332-17343. PubMed ID: 32297434
[TBL] [Abstract][Full Text] [Related]
19. Advances in engineering local drug delivery systems for cancer immunotherapy.
Abdou P; Wang Z; Chen Q; Chan A; Zhou DR; Gunadhi V; Gu Z
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Sep; 12(5):e1632. PubMed ID: 32255276
[TBL] [Abstract][Full Text] [Related]
20. Interfacing Biomaterials with Synthetic T Cell Immunity.
Su FY; Mac QD; Sivakumar A; Kwong GA
Adv Healthc Mater; 2021 Aug; 10(15):e2100157. PubMed ID: 33887123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
